Ustekinumab Dose Optimization in Crohn Disease: One Size Does Not Fit All

Inflamm Bowel Dis. 2021 May 17;27(6):e70. doi: 10.1093/ibd/izab019.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Crohn Disease* / drug therapy
  • Humans
  • Remission Induction
  • Ustekinumab*

Substances

  • Ustekinumab